Altered CXCR4 dynamics at the cell membrane impairs directed cell migration in WHIM syndrome patients.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
24 05 2022
Historique:
entrez: 19 5 2022
pubmed: 20 5 2022
medline: 24 5 2022
Statut: ppublish

Résumé

Chemokine receptor nanoscale organization at the cell membrane is orchestrated by the actin cytoskeleton and influences cell responses. Using single-particle tracking analysis we show that CXCR4R334X, a truncated mutant chemokine receptor linked to WHIM syndrome (warts, hypogammaglobulinemia, infections, myelokathexis), fails to nanoclusterize after CXCL12 stimulation, and alters the lateral mobility and spatial organization of CXCR4 when coexpressed. These findings correlate with multiple phalloidin-positive protrusions in cells expressing CXCR4R334X, and their inability to correctly sense chemokine gradients. The underlying mechanisms involve inappropriate actin cytoskeleton remodeling due to the inadequate β-arrestin1 activation by CXCR4R334X, which disrupts the equilibrium between activated and deactivated cofilin. Overall, we provide insights into the molecular mechanisms governing CXCR4 nanoclustering, signaling and cell function, and highlight the essential scaffold role of β-arrestin1 to support CXCL12-mediated actin reorganization and receptor clustering. These defects associated with CXCR4R334X expression might contribute to the severe immunological symptoms associated with WHIM syndrome.

Identifiants

pubmed: 35588454
doi: 10.1073/pnas.2119483119
pmc: PMC9173760
doi:

Substances chimiques

Actin Depolymerizing Factors 0
CXCR4 protein, human 0
Receptors, CXCR4 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2119483119

Références

Science. 1999 Jan 29;283(5402):655-61
pubmed: 9924018
Pharmacol Rev. 2001 Mar;53(1):1-24
pubmed: 11171937
Annu Rev Physiol. 2007;69:535-60
pubmed: 17002593
Proc Natl Acad Sci U S A. 2002 May 28;99(11):7478-83
pubmed: 12032308
Cell Motil Cytoskeleton. 2001 Jul;49(3):154-60
pubmed: 11668584
Immunity. 2004 May;20(5):589-99
pubmed: 15142527
Blood. 2005 Mar 15;105(6):2449-57
pubmed: 15536153
Proc Natl Acad Sci U S A. 2014 May 13;111(19):E1960-9
pubmed: 24778234
Trends Cell Biol. 2002 Mar;12(3):112-20
pubmed: 11859023
Cell Rep. 2019 Oct 22;29(4):995-1009.e6
pubmed: 31644919
J Biol Chem. 1999 Oct 22;274(43):31076-86
pubmed: 10521508
J Cell Sci. 2012 Dec 15;125(Pt 24):5917-26
pubmed: 23378019
Mol Cell. 2018 Apr 5;70(1):106-119.e10
pubmed: 29625032
Nat Cell Biol. 1999 Sep;1(5):321-2
pubmed: 10559946
J Biol Chem. 2007 Jul 13;282(28):20634-46
pubmed: 17500066
J Clin Invest. 2008 Mar;118(3):1074-84
pubmed: 18274673
J Cell Biol. 1999 Dec 27;147(7):1519-32
pubmed: 10613909
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15500-5
pubmed: 16223883
J Cell Biol. 2016 Feb 1;212(3):267-80
pubmed: 26833785
Mol Pharmacol. 2011 Nov;80(5):760-8
pubmed: 21836019
Nat Genet. 2003 May;34(1):70-4
pubmed: 12692554
Rep Prog Phys. 2015 Dec;78(12):124601
pubmed: 26511974
Science. 2001 May 25;292(5521):1502-6
pubmed: 11379633
J Biol Chem. 2004 Nov 19;279(47):49259-67
pubmed: 15364949
Blood. 2012 Jul 5;120(1):181-9
pubmed: 22596258
Biochim Biophys Acta. 2007 Apr;1768(4):952-63
pubmed: 17169327
Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12011-6
pubmed: 17620599
J Cell Sci. 2013 Oct 15;126(Pt 20):4614-26
pubmed: 23902692
Exp Hematol. 2005 Apr;33(4):460-8
pubmed: 15781337
Mol Cancer Ther. 2008 Nov;7(11):3490-8
pubmed: 19001433
Am J Respir Cell Mol Biol. 2010 Sep;43(3):269-75
pubmed: 19805483
J Biol Chem. 2008 Oct 24;283(43):29028-36
pubmed: 18678875
J Biol Chem. 2016 Dec 9;291(50):26083-26097
pubmed: 27789711
Nat Rev Immunol. 2004 Feb;4(2):110-22
pubmed: 15040584
J Biol Chem. 2002 Aug 23;277(34):30769-77
pubmed: 12065593
J Allergy Clin Immunol. 2005 Nov;116(5):1101-5
pubmed: 16275383
J Cell Mol Med. 2011 Oct;15(10):2071-81
pubmed: 21070597
Front Immunol. 2020 Sep 18;11:550824
pubmed: 33072091
Blood. 2007 Jan 1;109(1):78-84
pubmed: 16946301
Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15299-304
pubmed: 20686112
Clin Immunol. 2010 Jun;135(3):412-21
pubmed: 20226738
Blood. 2010 Oct 14;116(15):2803-11
pubmed: 20592249
Nat Immunol. 2004 Sep;5(9):943-52
pubmed: 15300245
Cell. 1995 Apr 7;81(1):53-62
pubmed: 7536630
J Clin Invest. 2003 Aug;112(4):566-74
pubmed: 12925697
Blood. 2017 Dec 7;130(23):2491-2498
pubmed: 29066537
J Cell Biol. 2005 Oct 24;171(2):349-59
pubmed: 16230460
Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6371-6
pubmed: 24733886
Mol Cell Biol. 2002 Feb;22(3):774-83
pubmed: 11784854
Curr Opin Hematol. 2009 Jan;16(1):20-6
pubmed: 19057201
J Vis Exp. 2019 Apr 9;(146):
pubmed: 31033950
Blood. 2015 Feb 12;125(7):1116-25
pubmed: 25355818
Mol Cell Biol. 2006 May;26(9):3432-45
pubmed: 16611986
Blood. 2008 Jul 1;112(1):34-44
pubmed: 18436740
Nat Rev Mol Cell Biol. 2010 Sep;11(9):633-43
pubmed: 20729930
Science. 2003 Dec 5;302(5651):1704-9
pubmed: 14657486
Biochem J. 2007 Dec 1;408(2):221-30
pubmed: 17680774
Annu Rev Biophys Biomol Struct. 2005;34:119-51
pubmed: 15869386
J Cell Sci. 2002 Feb 1;115(Pt 3):455-65
pubmed: 11861753
J Biol Chem. 2010 May 7;285(19):14318-29
pubmed: 20207744
PLoS One. 2009 Jul 09;4(7):e6148
pubmed: 19587789
J Immunol. 2008 Dec 15;181(12):8335-43
pubmed: 19050250
Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17655-60
pubmed: 21990345
Proc Natl Acad Sci U S A. 2016 Feb 9;113(6):E772-81
pubmed: 26798067
Blood. 2012 Jun 14;119(24):5722-30
pubmed: 22438253
J Exp Med. 1997 Jul 7;186(1):153-8
pubmed: 9207004
EMBO Rep. 2008 Dec;9(12):1244-50
pubmed: 18953287
J Biol Chem. 2002 Mar 15;277(11):9429-36
pubmed: 11777902
Cell Signal. 2013 Feb;25(2):457-69
pubmed: 23153585
J Biol Chem. 2001 Jan 5;276(1):670-6
pubmed: 11018042
J Cell Biol. 2007 Oct 22;179(2):239-45
pubmed: 17954607
Cell. 2020 Dec 23;183(7):1813-1825.e18
pubmed: 33296703
EMBO Rep. 2018 Nov;19(11):
pubmed: 30224411
Nature. 1998 May 7;393(6680):85-8
pubmed: 9590695

Auteurs

Eva M García-Cuesta (EM)

Chemokine Signaling Group, Department of Immunology and Oncology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, E-28049 Madrid, Spain.

José Miguel Rodríguez-Frade (JM)

Chemokine Signaling Group, Department of Immunology and Oncology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, E-28049 Madrid, Spain.

Sofía R Gardeta (SR)

Chemokine Signaling Group, Department of Immunology and Oncology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, E-28049 Madrid, Spain.
Department of Molecular Biosciences, Universidad Autónoma de Madrid, E-28049 Madrid, Spain.

Gianluca D'Agostino (G)

Chemokine Signaling Group, Department of Immunology and Oncology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, E-28049 Madrid, Spain.

Pablo Martínez (P)

Chemokine Signaling Group, Department of Immunology and Oncology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, E-28049 Madrid, Spain.

Blanca Soler Palacios (B)

Chemokine Signaling Group, Department of Immunology and Oncology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, E-28049 Madrid, Spain.

Graciela Cascio (G)

Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021.

Tobias Wolf (T)

Institute of Microbiology, ETH Zürich, 8092 Zürich, Switzerland.

Nicolas Mateos (N)

Institut de Ciencies Fotoniques, Barcelona Institute of Science and Technology, E-08860 Barcelona, Spain.

Rosa Ayala-Bueno (R)

Chemokine Signaling Group, Department of Immunology and Oncology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, E-28049 Madrid, Spain.

César A Santiago (CA)

X-ray Crystallography Unit, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, E-28049 Madrid, Spain.

Pilar Lucas (P)

Chemokine Signaling Group, Department of Immunology and Oncology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, E-28049 Madrid, Spain.

Lucia Llorente (L)

12 de Octubre Health Research Institute (imas12), E-28012 Madrid, Spain.

Luis M Allende (LM)

12 de Octubre Health Research Institute (imas12), E-28012 Madrid, Spain.

Luis Ignacio González-Granado (LI)

12 de Octubre Health Research Institute (imas12), E-28012 Madrid, Spain.
Department of Public Health School of Medicine, School of Medicine Universidad Complutense de Madrid, E-28040 Madrid, Spain.

Noa Martín-Cófreces (N)

Immunology Service, Hospital Universitario de la Princesa, UAM, IIS-IP, E-28006 Madrid, Spain.
Area of Vascular Pathophysiology, Laboratory of Intercellular Communication, Fundación Centro Nacional de Investigaciones Cardiovasculares-Carlos III, E-28029 Madrid, Spain.
Centro de Investigación Básica en Red cardiovascular, E-28029 Madrid, Spain.

Pedro Roda-Navarro (P)

12 de Octubre Health Research Institute (imas12), E-28012 Madrid, Spain.
Department of Immunology, Ophthalmology, and ENT, School of Medicine, Universidad Complutense de Madrid, E-28040 Madrid, Spain.

Federica Sallusto (F)

Institute of Microbiology, ETH Zürich, 8092 Zürich, Switzerland.
Institute for Research in Biomedicine, Bellinzona, Università della Svizzera Italiana, 6900 Lugano, Switzerland.

Francisco Sánchez-Madrid (F)

Immunology Service, Hospital Universitario de la Princesa, UAM, IIS-IP, E-28006 Madrid, Spain.
Area of Vascular Pathophysiology, Laboratory of Intercellular Communication, Fundación Centro Nacional de Investigaciones Cardiovasculares-Carlos III, E-28029 Madrid, Spain.
Centro de Investigación Básica en Red cardiovascular, E-28029 Madrid, Spain.

María F García-Parajo (MF)

Institut de Ciencies Fotoniques, Barcelona Institute of Science and Technology, E-08860 Barcelona, Spain.
Institutió Catalana de Recerca i Estudis Avançats, E-08010 Barcelona, Spain.

Laura Martínez-Muñoz (L)

Department of Cell Signaling, Centro Andaluz de Biología Molecular y Medicina Regenerativa, Consejo Superior de Investigaciones Cientificas, E-41092 Seville, Spain.
Department of Medical Biochemistry, Molecular Biology, and Immunology, University of Seville, Medical School, E-41004 Seville, Spain.

Mario Mellado (M)

Chemokine Signaling Group, Department of Immunology and Oncology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, E-28049 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH